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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
• To evaluate the effects of cognitive rehabilitation on everyday functioning and other outcomes for people with mild to moderate
dementia, and on outcomes for caregivers
• To identify and explore factors that may be associated with the efficacy of cognitive rehabilitation
B A C K G R O U N D
Description of the condition
Dementia is a general term for a number of progressive neu-
rodegenerative conditions, arising predominantly in later life. The
World Alzheimer Report 2015 estimates that there are 46.8 mil-
lion people living with dementia worldwide (Prince 2015). The
prevalence of dementia doubles every 6.3 years, from 3.9 per 1000
person-years in people 60 to 64 years old, to 104.8 per 1000
person-years for people over 90. Changes in lifestyle and conse-
quently, health status and life expectancy, translate into differ-
ences in incidence and prevalence rates between countries and
generations. Monitoring the prevalence of dementia is challeng-
ing. Data collected in different countries and across various studies
cannot be easily compared, due to the diagnostic process, which
involves neuropsychological evaluation, interviews, and observa-
tion, and is guided by changing diagnostic criteria (Wu 2017).
The general trend is for people to live longer, so regardless of these
factors, the number of people with dementia is expected to in-
crease to 74.7 million by 2030, and to 131.5 million by 2050.
The risk of dementia is higher for those with poorer cardiovas-
cular health, and with worse access to education and healthcare
(Prince 2015; Wu 2017).The most common form of dementia is
caused by Alzheimer’s disease, which accounts for approximately
62% of cases, followed by vascular dementia (17%), and mixed
Alzheimer’s and vascular dementia (10% (Prince 2014). Rarer
forms of dementia include the Parkinsonian dementias (Parkin-
son’s disease dementia, 2%, and dementia with Lewy bodies, 4%),
and the behavioural and semantic variants of frontotemporal de-
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mentia (2%).
Each type of dementia in the mild to moderate stages has its own
profile of cognitive changes, which can be demonstrated on neu-
ropsychological testing, although as dementia progresses further,
the differences become less distinguishable. A useful summary is
provided by Weintraub 2012. Alzheimer’s disease is characterised
by impairments in episodic memory; other cognitive domains,
such as executive function, are also affected. In vascular dementia,
episodic memory may be less impaired, while executive function-
ing, attention, and perception are more affected. Parkinsonian de-
mentias are characterised by impairment in attention, executive
function, and visual perception (Kudlicka 2011). Among the fron-
totemporal dementias, semantic dementia is characterised by loss
of conceptual knowledge and vocabulary; the behavioural variant
is characterised by executive dysfunction (Hodges 1992; Snowden
1989).
Cognitive impairments affect functional ability (Martyr 2012a;
Royall 2007). Impaired ability to function in daily life is a core
feature of dementia, progressing from mild difficulty with instru-
mental activities of daily living in the early stages, to dependence
on others for basic activities of daily living in the later, severe stages
(Boyle 2002; Njegovan 2001). Even in the early stages of demen-
tia, impaired functional ability impacts on independence, andmay
result in loss of confidence, and withdrawal from activities, leading
to what has been termed ‘excess’ or unnecessary additional disabil-
ity (Reifler 1990). Impairments in functional ability, and associ-
ated excess disability, contribute significantly to caregiver burden
(Martyr 2014; Razani 2007). Supporting functional ability, by en-
abling people with dementia to function at their best level, given
their underlying impairments, is potentially an important target
for intervention (Poulos 2017).
Description of the intervention
Cognitive rehabilitation is a personalised approach, based on a
problem-solving framework, which enables people with dementia
to engage in, or manage everyday activities, function optimally,
and maintain as much of their independence as possible. Reha-
bilitation denotes a positive approach to enabling people to make
the most of their functional ability; in some settings, especially
community settings, reablement is a more commonly used de-
scriptor (Poulos 2017). The terms cognitive rehabilitation, and
the equivalent, neuropsychological rehabilitation, were first intro-
duced to differentiate this approach from rehabilitation for phys-
ical disabilities. Cognitive, or neuropsychological, indicates that
the intervention addresses the impact of cognitive impairments
on everyday life, and on the engagement in everyday activities.
None of these terms imply that the underlying impairment can be
removed, or that there are attempts to restore or improve cognitive
function; instead, they emphasise a solution-focused approach to
manage the everyday challenges that result from the impairment
(McLellan 1991).
Originally developed for people living with cognitive impairment
as a result of brain injury (Wilson 2002), the cognitive rehabilita-
tion approachwas adapted for people with dementia, and is consis-
tent with the values of person-centred dementia care (Clare 2017).
Its goal is to support independence and social participation, in line
with many European and worldwide organisations that promote
strategies to maximise functional ability in the older population,
and those with dementia (EIPAHA 2012; Myshra 2016; WHO
2001). It also recognises the right of people with dementia to re-
ceive support that enables them to reach their best possible level
of functioning. This may be important for the sustainability of
healthcare systems, as improved functioning in everyday activi-
ties may potentially reduce the need for paid support, unnecessary
hospitalisation (Clare 2017), and prevent premature admission to
a care home (Amieva 2016). Cognitive rehabilitation practitioners
may be drawn from a number of professional backgrounds, such
as clinical psychology, occupational therapy or nursing. Often, a
qualified practitioner will supervise less qualified staff, such as as-
sistant psychologists or occupational therapy technicians. Other
groups of staff, such as home support workers, may be trained to
implement this approach under supervision.
The goal of cognitive rehabilitation is to improve functioning in
areas that the recipient identifies as relevant and important to them
(Clare 2008). These targeted areas are typically outlined in the
form of personal goals that the individual wishes to attain. Cogni-
tive rehabilitation for people with dementia is usually conducted
in the person’s home setting, or the environment in which the tar-
geted activities generally occur. Transfering new learning to differ-
ent situations is a challenge in behavioural interventions, and this
can be avoided by working directly in the context in which the
new skills will be used. Consequently, cognitive rehabilitation is
usually offered as an individual intervention, rather than in group
formats.
If cognitive impairments have progressed to the point where the
person does not readily understand or engage in the rehabilitation
process, the practitioner may use the cognitive rehabilitation ap-
proach to help the caregivers (e.g. family members, care workers,
care home staff, or home support staff ) develop more effective
strategies to support and enable the person with dementia. How-
ever, this review will consider interventions for people with mild
to moderate dementia, who are still able to engage in the process
of identifying their rehabilitation goals.
During the goal-setting process, the cognitive rehabilitation prac-
titioner works with each individual to identify the areas of daily
life in which they wish to improve. The practitioner assesses:
1. The person. The practitioner needs to understand the
person’s current level of functioning, where difficulties arise and
why, and whether the person could potentially function better if
secondary issues, such as loss of confidence, or lack of necessary
support, were to be addressed.
2. The context. The practitioner needs to understand the
environment in which the person is operating, and factors that
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could either facilitate or hinder progress towards the achievement
of their personal goals. This includes the nature of the
relationship with family members or friends, and the level of
support that might be forthcoming. Family members may have
their own priority areas to be addressed, and negotiation may be
required to arrive at a set of goals that meets the needs and wishes
of both parties.
3. The activity. The practitioner needs to understand the
nature and demands of each activity or task that the person
wishes to manage better, the steps involved in completing it, and
what strategies, if any, have already been tried. If the person is
currently doing the activity, the practitioner needs to identify
where any problems or difficulties arise, and what needs to
change to enable the activity to be undertaken more successfully.
Based on this assessment, the practitioner clarifies the goals, en-
sures they are realistic, and draws on a set of evidence-based or
practice-tested methods and techniques to prepare an individual
rehabilitation plan. This may include methods to:
• Engender procedural learning through developing habits
and routines, for example designate and use a specific place to
leave important personal items, learn to make calls and send
messages on a smart phone, or use a dosette box to manage
medication.
• Reactivate previous knowledge, for example remember and
use the names of one’s grandchildren.
• Compensate for known difficulties and challenges, for
example develop strategies to avoid being distracted and lose
concentration when preparing meals, modify tasks or the
environment, or introduce assistive technology.
• Build individual strategies to support functioning in
specific situations, for example join the conversation at the
family dinner table, or re-engage in a previously enjoyed activity.
• Address specific dementia-related difficulties, for example
reactivate knowledge of vocabulary and concepts for people with
semantic dementia.
Evidence-based techniques used in cognitive rehabilitation inter-
ventions include both enhanced learning methods and introduc-
tion of compensatory strategies. Enhanced learning methods in-
clude modelling; prompting, with gradual fading of prompts; and
expanding the rehearsal of information (Clare 2008).While error-
less learning approaches are sometimes recommended, evidence
suggests that reducing or removing errors during learning does not
confer benefits for people with dementia, although making fewer
errors may make learning more congenial by reducing the experi-
ence of failure (Dunn 2007; Voigt-Radloff 2017). Some activities
will be broken down into steps, and practised, one step at a time,
until the whole sequence of steps has been mastered. Compen-
satory strategies and memory aids may be introduced, with the
support of the cognitive rehabilitation practitioner, where appro-
priate.
The cognitive rehabilitation practitioner works with the person,
and where appropriate, with his or her family or other supporters,
to implement the rehabilitation plan. The practitioner encourages
supporters to learn the techniques, so that they can facilitate be-
tween-session practice. As people differ in how they respond to
particular strategies and techniques, the practitioner may need to
trymore than one strategy to identify the approach that works best
for a given individual. Therefore, the practitioner might adapt the
rehabilitation plan, based on ongoing evaluation of its progress,
and assessment of the extent to which goals are achieved. Addi-
tional elements may be incorporated into the intervention where
needed, for example an individual may need to develop anxiety
management skills before advancing to selected goals. The level of
support may vary in length and number of sessions, and the extent
to which the broader personal and social context is addressed, for
example it may include help to manage depression and anxiety, or
offer support for family members.
In research trials, the cognitive rehabilitation approach may be
adapted in order to allowmore definedmethods of evaluation. For
example, a researcher who is not the treating therapist, may set
goals and rate progress; this means that therapists may be working
with goals to which they had no prior input. Goals may also be
selected from a pre-defined list, rather than developing them de
novo with the individual. Progress may be evaluated through self-
or informant ratings in relation to goals, observation of perfor-
mance, or objective tests, rather than therapist evaluation of out-
comes (Clare 2019a; Voigt-Radloff 2017).
How the intervention might work
Cognitive rehabilitation is a behaviour change intervention, based
on an understanding of the cognitive changes seen in mild to
moderate dementia, which builds on relatively better preserved
cognitive abilities to address and overcome the impact of cogni-
tive impairment. It has long been understood that people with
mild to moderate dementia have considerable retained cognitive
and behavioural capacities, and are capable of behaviour change
and some new learning, given appropriate support (Backman
1992; Fernández-Ballesteros 2003; Little 1986). For example, in
Alzheimer’s, vascular and mixed dementia memory problems are
common. Neuropsychological models distinguish different types
and processes of memory, and experimental studies show that
these different types of memory are differentially affected; episodic
memory (memory for events and personal experiences) is im-
paired, but procedural memory (learned habits and routines) is
relatively spared in people with mild to moderate stages of these
types of dementia (Squire 1995). Therefore, by providing strate-
gies that draw on relatively preserved processes, it is possible to
compensate for the results of more severe impairment in other
areas (Bahar-Fuchs 2013).
Psychologically, the experience of successfully achieving goals and
improving everyday function could increase feelings of self-effi-
cacy, and help to counter negative consequences of dementia, such
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as loss of confidence, thus reducing excess disability (Marshall
2005).
Family members, or other supporters may benefit in a number of
ways. They may feel less burdened as the person with dementia
functions better in targeted areas of daily life. They are supported
to learn some of the rehabilitative strategies themselves, and can
apply them when new difficulties arise after the therapy sessions
end. Involvement in the therapy process can improve understand-
ing of dementia and the person’s behaviour, which in turn, enables
them to have more patience with the person with dementia, and
improve the relationship overall (Clare 2019b).
Why it is important to do this review
Impairments in functional ability form part of the diagnostic cri-
teria for dementia, and are a defining characteristic of the con-
dition (APA 2013; WHO 1992). Among people with dementia,
better functional ability is associated with higher self- and infor-
mant-ratings of quality of life (Bosboom 2012; Dourado 2016;
Gómez-Gallego 2012; Heggie 2012; Martyr 2018; Ready 2004;
Sheehan2012;Woods 2014). Inmild tomoderate dementia, there
is a significant decline in ability to carry out instrumental activ-
ities of daily living. Diminished functional ability impacts inde-
pendence, adds to caregiver burden, and can result in a loss of
confidence and withdrawal from activities (McLaughlin 2010).
Despite this, limited attention has been paid to strategies that sup-
port functional ability. Cognitive rehabilitation, if effective, could
form a valuable component of support for people with dementia
and their families.
In previous Cochrane Reviews, cognitive rehabilitation was in-
cluded with cognitive training, and the most recent update found
only one randomised controlled trial of cognitive rehabilitation
(Bahar-Fuchs 2013). For the present review, we separate these two
interventions; first, because they are radically different, and sec-
ond, because the volume of evidence relating to cognitive rehabil-
itation is gradually increasing.
O B J E C T I V E S
• To evaluate the effects of cognitive rehabilitation on
everyday functioning and other outcomes for people with mild
to moderate dementia, and on outcomes for caregivers
• To identify and explore factors that may be associated with
the efficacy of cognitive rehabilitation
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will consider randomised controlled trials (RCTs) that com-
pare cognitive rehabilitation with treatment as usual, a waiting-
list control, a non-specific active control intervention, or an alter-
native treatment intervention. We will consider a cross-over de-
sign if there are sufficient data available for the first period only
(Elbourne 2002). We will exclude other study designs to limit the
risk of bias in estimates of treatment effects (Reeves 2011).We will
not impose any language or date restrictions in the search strategy.
For possibly-relevant studies published in a language other than
English, we will attempt to obtain translation. If a translation is
not available prior to submission of the completed review, we will
file the studies under ’awaiting classification’.
Studies must include, at a minimum, baseline and post-treatment
evaluations. Further follow-up, where available, may be of any
duration.
Types of participants
Participant characteristics: adults of any age and background.
Theymay, ormay not, have an unpaid caregiver (spouse or partner,
family member, or friend) who supports their participation, and
provides relevant information.
Diagnosis: dementia, of any type, made according to established
clinical and research criteria; for example:
• The Diagnostic and Statistical Manual of Mental Disorders,
fifth edition (DSM-V (APA 2013)), or earlier versions (APA
1995)
• The International Classification of Diseases, tenth revision
(ICD-10 (WHO 1992))
• The National Institute of Neurological and
Communicative Disorders - Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA (McKhann 1984))
• The National Institute of Health - Alzheimer’s Association
(NIA-AA (McKhann 2011))
• The Association Internationale pour la Recherché et
l’Enseignement en Neurosciences (NINDS-AIREN (Román
1993))
• Vascular Impairment of Cognition Classification Consensus
Study (McKeith 1996; McKeith 2006; McKeith 2017)
• The International Behavioural Variant FTD Criteria
Consortium (FTDC (Skrobot 2018))
Stage of dementia: mild to moderate level of severity, on average,
as indicated by group mean scores, score ranges, or individual
scores, on measures used to indicate dementia severity. We will
use an internationally recognised dementia staging system, the
Clinical Dementia Rating (CDR 2), as a reference, along with
equivalent scores of another screening tests (Hughes 1982). Mild
to moderate level of severity will be indicated by scores of 0.5 to 2
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on the CDR; 11 or above on the Mini-Mental State Examination
(MMSE (Folstein 1975)); a Montreal Cognitive Assessment raw
score of 5 or above (MoCA (Nasreddine 2005; Roalf 2013)), or
an Addenbrooke’s Cognitive Examination (ACE-III and ACE-R)
score of 27 or above (Matías-Guiu 2018; Perneczky 2006). We
will not set an upper limit for screening test scores, as the study
participants will have to have a diagnosis of dementia. We will
include studies where fewer than 20% of participants fall outside
of themild tomoderate level of severity, provided this information
is clearly indicated.
Pharmacological treatment: participants in both the intervention
and control groups may be receiving concurrent pharmacological
treatment for dementia as a randomly distributed covariate.Where
available, we will note information about participants’ use of such
medication, including information about whether participants are
receiving a stable dose.
Types of interventions
We will include interventions that meet our definition of cogni-
tive rehabilitation. Terminology in the field of non-pharmacolog-
ical interventions for people with dementia is inconsistent, and
researchers may use alternative terms such as reablement or reme-
diation. In some cases, the term cognitive rehabilitation may be
incorrectly applied to describe different approaches, such as cog-
nitive training or cognitive stimulation. Cognitive rehabilitation
protocols may vary considerably across clinical practice and re-
search trials. For example, cognitive rehabilitation could form part
of a comprehensive programme that includes formal therapy for
mood disorders and counselling for family members, or the term
could refer to a set of techniques that address memory or attention
difficulties (Kudlicka 2018). We will define cognitive rehabilita-
tion as a therapy that encompasses interventions that:
• Focus on functioning in everyday activities;
• Address specific targeted activities chosen or identified as
important by each individual participant. These activities will
usually be expressed in terms of personal goals that the
participant wishes to achieve;
• Apply an individual, personalised therapy plan, aimed at
improving performance in, or management of, these activities,
based on an assessment of the person’s current functioning and
intrinsic capacity, and on an evaluation of the demands of the
targeted activities;
• Use recognised rehabilitative strategies and methods to
enable the person to compensate for, manage, or overcome
functional limitations, with regard to the targeted activities.
For the purposes of selecting studies for this review, we will oper-
ationalise this definition as:
1. It aims to improve functioning in everyday activities (i.e.
not on abstract exercises, puzzles, or tests);
2. It is personalised, as indicated by at least one of the
following:
• The therapy objective is chosen by the person with
dementia, or a family supporter, or both and may be selected
from a list;
• The therapy plan is based on an assessment of the person’s
current functioning and capacity; or
• The therapy strategies reflect the person’s ability and
therapy objective (i.e. the intervention does not use the same
method for every person, every goal, or both)
3. It uses recognised cognitive rehabilitation techniques, including




• Expanding rehearsal (also known as spaced retrieval);
• Prompting and fading;
• Altering features of the person’s environment and
surroundings;
• Mnemonics, elaboration, and vanishing cues for learning or
relearning information; or
• Introducing compensatory strategies such as memory aids.
The practitionerwill usually deliver the intervention in the person’s
home setting, or in the everyday environment inwhich the targeted
activities are undertaken, and provide it on a one-to-one basis, over
several sessions. We will consider interventions provided in group
formats, if they meet the above criteria. In some cases, cognitive
rehabilitationmay be combinedwith other interventions delivered
at the same time, such as cognitive training or physical exercise
(Bahar-Fuchs 2019).We will exclude trials where this is the case, as
it will not be possible to determine the distinct contributionof each
intervention element to the outcomes of interest. We will retain
studies if the review authors judge that cognitive rehabilitation
comprises at least 80% of the actual intervention time.
Comparators
Cognitive rehabilitation may be compared to inactive controls
(treatment as usual, a waiting-list control condition), a non-spe-
cific active control intervention, or an alternative treatment:
• Treatment as usual. This may be described as standard
treatment, usual treatment, or no treatment. In this review, usual
treatment alone is compared to usual treatment plus cognitive
rehabilitation. Usual treatment refers to the treatment usually
available in the study locality, and might include memory clinic
consultations, provision of medication, contact with a
community mental health team, day care, or support from
voluntary organisations.
• Waiting-list control. Participants allocated to the control
group receive no intervention but are informed that they will be
offered cognitive rehabilitation once the trial has ended.
• Non-specific active control. Participants allocated to the
control group engage in a specified activity for an equivalent
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number of sessions and have similar levels of contact with the
research team, but do not receive a cognitive rehabilitation
intervention or other structured intervention.
• Alternative treatment. Participants in the comparator
group receive another recognised non-pharmacological
intervention, which has different components. Non-
pharmacological interventions fall into the following three
categories that will be used to group alternative treatments:
cognition-focused (e.g. reminiscence therapy, cognitive
stimulation therapy, brain training), exercise-based (e.g. aerobic
training, resistance training), or arts-based (e.g. music therapy,
drama therapy).
Use of different comparators is likely to constitute an important
source of heterogeneity in the findings.
Types of outcome measures
We will consider behavioural, cognitive, and psychosocial out-
comes which are measured at the end of treatment, or at follow-
up. Biomarker and economic outcomes are beyond the scope of
this review.
Primary outcomes
• Functional ability in targeted activities. The primary
outcome of a cognitive rehabilitation intervention is the effect on
participants’ functional ability to engage in, and carry out the
activities specifically targeted in the intervention (Wilson 2002).
This may be assessed by means of ratings of performance on a
standard scale made by the participant, caregiver, or therapist (or
a combination), or through direct observation and recording of
performance on specific tasks. An example of a standard scale for
rating the attainment of therapy goals is the Canadian
Occupational Performance Measure (Law 2005). An example of
an observational measure is the Direct Measure of Training
(Thivierge 2014).
Secondary outcomes
• General functional ability. A key secondary outcome is the
effect on general functional ability, assessed by informant ratings
on a standardised scale, such as the Functional Activities
Questionnaire (Martyr 2012b; Pfeffer 1982), or a reduction in
dependence, assessed by informant ratings on a standardised
scale, such as the Dependence Scale (Brickman 2002; Stern
1994).
Other secondary outcomes for the person with dementia are:
• self-efficacy,
• mood,
• quality of life,
• cognition (global and domain-specific), and
• disease severity




• quality of life.
We will prioritise published and validated measures, and only ac-
cept a non-established measure if we find sufficient evidence to
support its statistical properties. In classifying cognitive measures,
we will use well-established classifications (e.g. Strauss 2006).
Where there are multiple measures for the same outcome, we will
follow principles described in Bahar-Fuchs 2019).
Search methods for identification of studies
Electronic searches
We will search ALOIS (www.medicine.ox.ac.uk/alois), the
Cochrane Dementia and Cognitive Improvement Group (CD-
CIG) specialised register. ALOIS is maintained by the Informa-
tion Specialists for the Cochrane Dementia and Cognitive Im-
provementGroup, and contains studies that fall within the areas of
dementia prevention, dementia treatment and management, and
cognitive enhancement in healthy older people. The studies are
identified through:
1. Searching a number of major healthcare databases:
MEDLINE, Embase, CINAHL, and PsycINFO;
2. Searching a number of trial registers: ClinicalTrials.gov and
the World Health Organization International Clinical Trials
Register Platform (ICTRP), which covers ISRCTN; the Chinese
Clinical Trials Register; the German Clinical Trials Register; the
Iranian Registry of Clinical Trials; and the Netherlands National
Trials Register;
3. Searching the Central Register of Controlled Trials
(CENTRAL) in the Cochrane Library;
4. Searching grey literature sources: ISI Web of Science Core
Collection.
To view a list of all sources searched for ALOIS, please visit the
ALOIS website: www.medicine.ox.ac.uk/alois.
Details of the search strategies run in healthcare bibliographic
database and used for the retrieval of reports of dementia, cognitive
improvement, and cognitive enhancement trials can be viewed
on the Cochrane Dementia and Cognitive Improvement Group
website: http://dementia.cochrane.org/searches.
We will run additional searches in MEDLINE, Embase,
PsycINFO, CINAHL, LILACs, ClinicalTrials.gov, and theWHO
Portal/ICTRP to ensure that the searches for this review are as
comprehensive and current as possible. See Appendix 1 for the
search strategy we will use to retrieve reports of trials from MED-
LINE Ovid (Appendix 1).
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Searching other resources
We will screen reference lists of included trials, and of relevant
systematic reviews and practice guidelines identified during the
screening process.
Data collection and analysis
Selection of studies
We will prepare a complete list of search results, with duplicate
records removed.Wewill test the eligibility criteria on a selectionof
10 to 12 studies, and will refine and clarify the criteria to maximise
consistency of the screening process. Two review authors, working
independently, will screen titles and abstracts, and exclude articles
that both review authors agree are ineligible. We will discuss any
disagreements on eligibility, and if we cannot reach consensus, will
refer the abstract in question to a third review author. Where there
is any doubt, we will retain the abstract. We will retrieve the full-
text articles for all abstracts retained at this stage, and two review
authors, working independently, will review them.We will discuss
any disagreements on eligibility, and if we cannot reach consensus,
will refer the article in question to a third review author. We will
group multiple reports from the same trial under a single study
identifier. We will contact study authors for further details if we
require clarification. To prevent any conflicts of interest arising,
review team members who have authored reports of studies being
considered for inclusion at any stage of the selection process will
not be involved in decisions about the inclusion of those studies;
instead, we will refer the studies to other review teammembers for
a decision.
Data extraction and management
We will prepare and use a structured proforma for data extraction,
from which we will transfer and manage data in Review Manager
5.
From each trial, we will extract data, including detailed charac-
teristics of the trial, its setting, design and outcomes; participant
characteristics (diagnosis, age, gender, education, dementia sever-
ity and medication use); and the experimental and comparator in-
terventions (nature, intensity, frequency, and duration). For each
outcome of interest, we will extract means and standard devia-
tions of relevant measures from all available evaluations. Where
available, we will also extract information about potential effect
moderators: adherence and retention, intervention integrity and
fidelity, and adverse events.
Assessment of risk of bias in included studies
Two review authors, working independently, will use theCochrane
’Risk of bias’ tool to assess bias in the domains of sequence gen-
eration, allocation concealment, blinding of participants and in-
vestigators, incomplete outcome data, and selective reporting of
outcomes (Higgins 2017). We will refer disagreements that we
cannot resolve through discussion to a third review author. We
will rate studies as low risk, high risk or unclear risk in each of
these domains. Review teammembers will not rate any studies for
which they are co-authors; these studies will be referred to other
team members for rating.
Measures of treatment effect
For continuous outcomes, we will use the mean difference (MD)
with 95% confidence interval (CI) when studies used the same
rating scale to measure a particular outcome, and the standardised
mean difference (SMD), which is the absolute mean difference
divided by the pooled standard deviation, when the same outcome
is assessed by different rating scales. We will calculate effect esti-
mates, with 95% CIs, using change-from-baseline scores. Baseline
is defined as the latest available assessment prior to randomisation,
undertaken notmore than twomonths beforehand.Where change
scores are not reported, we will extract the mean, standard devi-
ation, and number of participants at each assessment point, for
each group, and calculate the change scores. We will base calcula-
tions of the standard deviation of change scores on an assumption
that the correlation between measurements at baseline and those
at subsequent time points is zero. This method overestimates the
standard deviation of the change frombaseline, but it is considered
preferable in a meta-analysis to take a conservative approach.
For dichotomous outcomes (e.g. institutionalisation), we will ex-
press effects as risk ratios (RR), along with 95% CIs.
We will decide whether to treat ordinal outcome data as contin-
uous, or to dichotomise, following data extraction, depending on
the number of categories. We will treat outcome measures with
more than 10 categories as continuous variables arising from a
normal distribution (Bahar-Fuchs 2019).
Unit of analysis issues
Cross-over trials
We will use data from the first treatment period, prior to cross-
over, only.
Trials with multiple comparator conditions
We will conduct separate analyses for each type of comparator,
where sufficient data are available. Alternative treatments serving as
comparators will be grouped by category (e.g. cognition-focused,
exercise-based, arts-based) to facilitate comparison across studies.
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Duration of follow-up
As follow-up durations will vary, we will group these for purposes
of analysis in bands of time since the end of treatment assessment
to facilitate comparisons (i.e. 3 to 6 months, 7 to 12 months, 13
to 18 months, 19 to 24 months, and > 24 months). Where a given
study has more than one assessment point within a time band, we
will use data from the latest assessment. We will note any contact
with the research team during the follow-up period (for example,
for maintenance or ‘booster’ sessions).
Dealing with missing data
We will identify the number of participants included in the fi-
nal analysis as a proportion of all participants recruited and ran-
domised.
Assessment of heterogeneity
In addition to visual inspection of forest plots, we will assess statis-
tical heterogeneity using a standard Chi² statistic and the associ-
ated I² statistic (Higgins 2003). We will consider heterogeneity to
be substantial when the Chi² statistic is significant at the P = 0.1
level, or when the I² suggests that more than 40% of the variability
in effect estimate is due to heterogeneity (Deeks 2017).
Assessment of reporting biases
For the primary outcomes, we will evaluate the presence of report-
ing bias through a visual examination of funnel plots if 10 or more
studies are included in a meta-analysis (Egger 1997).
Data synthesis
We will conduct data synthesis in Review Manager 5.
For each outcome of interest, where available data permit, we will
undertake the following separate comparisons:
• Cognitive rehabilitation versus control (inactive and non-
specific active controls) at the end of therapy.
• Cognitive rehabilitation versus control (inactive and non-
specific active controls) at subsequent follow-up.
• Cognitive rehabilitation versus alternative treatment at the
end of therapy.
• Cognitive rehabilitation versus alternative treatment at
subsequent follow-up.
For alternative treatment comparators, we will conduct separate
analyses for the following categories of comparator: cognition-
focused, exercise-based, and arts-based interventions.
For multiple follow-ups, we will group comparable time points,
and conduct separate analyses for each time point.
Within each of the planned comparisons, we will pool data in
relation to each outcome of interest when data from at least two
trials are available. We will conduct inverse-variance, random-ef-
fects meta-analyses for all outcomes.
GRADE and ’Summary of findings’ tables
We will apply the GRADE framework to all primary and sec-
ondary outcomes in each comparison, classifying the certainty of
evidence as high, moderate, low or very low. We will include this
classification in the ’Summary of findings’ (SoF) tables. For each
comparison, we will use GRADEpro GDT software to generate
’SoF’ tables for the following primary and secondary outcomes:
• Functional ability in targeted activities
• General functional ability
• Self-efficacy
• Mood
• Quality of life
• Cognition (global)
• Quality of life (caregivers)
Subgroup analysis and investigation of heterogeneity
In relation to each outcome, we will carry out sub-group analyses
if there is evidence of substantial heterogeneity, and there are at
least three studies per subgroup. These analyses will evaluate the
potential impact of the following factors that might modify ob-
served treatment effects:
• Intervention intensity (number of sessions and duration of
intervention period)
• Type of dementia
• Type of practitioner (practitioner profession and
qualification level)
• Risk of bias (studies with high or unclear risk of bias in two
or more domains versus studies with less risk of bias)
• Registration status of the trial (registered versus not
registered)
• Type of control condition (inactive versus non-specific
active control)
Sensitivity analysis
Where indicated by the data we will use sensitivity analyses to
clarify uncertainties relating to eligibility criteria, data, and analysis
methods in the identified studies, following Cochrane guidelines.
For example, in the presence of substantial heterogeneity, we will
explore the effect of small studies by comparing fixed-effect and
random-effects estimates; we will use a ‘trim and fill’ technique to
address publication bias.
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Appendix 1. Search strategy for MEDLINE Ovid
1 exp Dementia/
2 exp DELIRIUM/
3 exp Neurocognitive Disorders/
4 exp Aphasia, Primary Progressive/








13 (pick* adj2 disease).ti,ab.
14 (lewy* adj2 bod*).ti,ab.
15 (creutzfeldt or jcd or cjd).ti,ab.
16 (chronic adj2 cerebrovascular).ti,ab.
17 (cerebral* adj2 insufficient*).ti,ab.
18 (cerebr* adj2 deteriorat*).ti,ab.
19 (“normal pressure hydrocephalus” and “shunt*”).ti,ab.
20 “primary progressive aphasia”.ti,ab.
21 “Parkinson* disease dementia”.ti,ab.
22 “organic brain syndrome”.ti,ab.
23 “organic brain disease”.ti,ab.
24 “major neurocognitive disorder*”.ti,ab.
25 “benign senescent forgetfulness”.ti,ab.
26 or/1-25
27 exp Cognitive Remediation/
28 exp Cognitive Remediation/
29 exp Cognitive Therapy/
30 exp Rehabilitation Nursing/
31 “activities of daily living”.ti,ab.
32 “Cog* retrain*”.ti,ab.
33 “cognitive intervention*”.ti,ab.
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48 (cognit* adj2 rehabilitation).ti,ab.
49 (cognit* adj2 retrain*).ti,ab.
50 (cognit* adj2 stimulation).ti,ab.
51 (cognit* adj2 training).ti,ab.
52 (memory adj2 rehabilitation).ti,ab.
53 (memory adj2 therap*).ti,ab.
54 “restorative care”.ti,ab.
55 reablement.ti,ab.
56 (rehabilitation/ or rehab*.ti,ab.) and (activities of daily living/ orAttention/ or executive function/ or attention.ti,ab. or planning.ti,ab.
or “activities of daily living”.ti,ab. or “executive function”.ti,ab.)
57 or/27-56
58 26 and 57
59 randomized controlled trial.pt.








68 exp animals/ not humans.sh.
69 67 not 68
70 58 and 69
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